Literature DB >> 9362162

Short-term cessation of hormone replacement therapy and improvement of mammographic specificity.

J A Harvey1, J V Pinkerton, C R Herman.   

Abstract

Mesh：

Year:  1997        PMID： 9362162     DOI： 10.1093/jnci/89.21.1623

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

Review 1.  Clinical practice. Mammographic screening for breast cancer.

Authors:  Suzanne W Fletcher; Joann G Elmore
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

2.  Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension.

Authors:  Erin J Aiello Bowles; Melissa L Anderson; Susan D Reed; Katherine M Newton; E Dawn Fitzgibbons; Deborah Seger; Diana S M Buist
Journal:  J Womens Health (Larchmt)       Date:  2010-08       Impact factor: 2.681

3.  Circulating levels of inflammatory markers and mammographic density among postmenopausal women.

Authors:  Katherine W Reeves; Joel L Weissfeld; Francesmary Modugno; Brenda Diergaarde
Journal:  Breast Cancer Res Treat       Date:  2010-11-11       Impact factor: 4.872

Review 4.  Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.

Authors:  Emma C Atakpa; Mangesh A Thorat; Jack Cuzick; Adam R Brentnall
Journal:  Cochrane Database Syst Rev       Date:  2021-10-26

5.  Short-term (1-2 mo) hormone therapy cessation before mammography.

Authors:  Susan D Reed; Diana S M Buist; Melissa L Anderson; Erin J Aiello Bowles; Dawn Fitzgibbons; Deborah Seger; Katherine M Newton
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

6.  Endometriosis and mammographic density measurements in the Nurses' Health Study II.

Authors:  Leslie V Farland; Rulla M Tamimi; A Heather Eliassen; Donna Spiegelman; Kimberly A Bertrand; Stacey A Missmer
Journal:  Cancer Causes Control       Date:  2016-08-22       Impact factor: 2.506

7.  Short-term hormone therapy suspension and mammography recall: a randomized trial.

Authors:  Diana S M Buist; Melissa L Anderson; Susan D Reed; Erin J Aiello Bowles; E Dawn Fitzgibbons; Juleann C Gandara; Deborah Seger; Katherine M Newton
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

8.  Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.

Authors:  Shadi Azam; Theis Lange; Stephanie Huynh; Arja R Aro; My von Euler-Chelpin; Ilse Vejborg; Anne Tjønneland; Elsebeth Lynge; Zorana J Andersen
Journal:  Cancer Causes Control       Date:  2018-04-18       Impact factor: 2.506

Review 9.  Postmenopausal hormone therapy and breast cancer: a clinician's message for patients.

Authors:  Leon Speroff
Journal:  Endocrine       Date:  2004-08       Impact factor: 3.925

10.  Changes in magnetic resonance mammography due to hormone replacement therapy.

Authors:  Stefan O R Pfleiderer; Steffen Sachse; Dieter Sauner; Christiane Marx; Ansgar Malich; Susanne Wurdinger; Werner A Kaiser
Journal:  Breast Cancer Res       Date:  2004-03-16       Impact factor: 6.466
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.